The estimated Net Worth of Brian Smith is at least 371 千$ dollars as of 15 February 2018. Brian Smith owns over 20,000 units of Orasure Technologies stock worth over 119,319$ and over the last 7 years Brian sold OSUR stock worth over 251,374$.
Brian has made over 3 trades of the Orasure Technologies stock since 2017, according to the Form 4 filled with the SEC. Most recently Brian exercised 20,000 units of OSUR stock worth 119,200$ on 15 February 2018.
The largest trade Brian's ever made was exercising 20,000 units of Orasure Technologies stock on 15 February 2018 worth over 119,200$. On average, Brian trades about 8,047 units every 44 days since 2017. As of 15 February 2018 Brian still owns at least 28,075 units of Orasure Technologies stock.
You can see the complete history of Brian Smith stock trades at the bottom of the page.
Brian's mailing address filed with the SEC is 220 EAST FIRST STREET, , BETHLEHEM, PA, 18015.
Over the last 21 years, insiders at Orasure Technologies have traded over 21,897,384$ worth of Orasure Technologies stock and bought 196,200 units worth 1,037,188$ . The most active insiders traders include Douglas A Michels、Ronald H Spair、Michael J Gausling. On average, Orasure Technologies executives and independent directors trade stock every 43 days with the average trade being worth of 221,123$. The most recent stock trade was executed by Kathleen Gallagher Weber on 19 December 2023, trading 24,129 units of OSUR stock currently worth 194,238$.
based in bethlehem, pennsylvania, orasure technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. these products include tests for the detection of antibodies to the hiv virus, including the oraquick® in-home hiv test, oraquick advance® rapid hiv-1/2 antibody test and the orasure® hiv-1 oral specimen collection device, a test for antibodies to the hcv virus, the oraquick® hcv rapid antibody test, and oral fluid testing solutions for drugs of abuse testing, including intercept® oral fluid drug testing system and q.e.d.® saliva alcohol test. orasure also manufactures and sells several leading cryosurgical products. these include: histofreezer®, a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions, sold to the professional or physician office market, as well as an over-the-counter product fo
Orasure Technologies executives and other stock owners filed with the SEC include: